Genedx Holdings Corp Stock Market Value
| WGS Stock | 79.43 1.09 1.35% |
| Symbol | GeneDx |
GeneDx Holdings Corp Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GeneDx Holdings. If investors know GeneDx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GeneDx Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.09) | Revenue Per Share 10.113 | Quarterly Revenue Growth 0.442 | Return On Assets (0.08) | Return On Equity (0.36) |
The market value of GeneDx Holdings Corp is measured differently than its book value, which is the value of GeneDx that is recorded on the company's balance sheet. Investors also form their own opinion of GeneDx Holdings' value that differs from its market value or its book value, called intrinsic value, which is GeneDx Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GeneDx Holdings' market value can be influenced by many factors that don't directly affect GeneDx Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GeneDx Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if GeneDx Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GeneDx Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
GeneDx Holdings 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to GeneDx Holdings' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of GeneDx Holdings.
| 10/30/2024 |
| 11/29/2024 |
If you would invest 0.00 in GeneDx Holdings on October 30, 2024 and sell it all today you would earn a total of 0.00 from holding GeneDx Holdings Corp or generate 0.0% return on investment in GeneDx Holdings over 30 days. GeneDx Holdings is related to or competes with Privia Health, HealthStream, Certara, National Research, Definitive Healthcare, EUDA Health, and Aclarion. GeneDx Holdings is entity of United States More
GeneDx Holdings Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure GeneDx Holdings' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess GeneDx Holdings Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.82 | |||
| Information Ratio | 0.1793 | |||
| Maximum Drawdown | 57.06 | |||
| Value At Risk | (6.05) | |||
| Potential Upside | 9.21 |
GeneDx Holdings Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for GeneDx Holdings' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as GeneDx Holdings' standard deviation. In reality, there are many statistical measures that can use GeneDx Holdings historical prices to predict the future GeneDx Holdings' volatility.| Risk Adjusted Performance | 0.1592 | |||
| Jensen Alpha | 1.37 | |||
| Total Risk Alpha | 0.3298 | |||
| Sortino Ratio | 0.3508 | |||
| Treynor Ratio | 2.08 |
GeneDx Holdings Corp Backtested Returns
GeneDx Holdings is not too volatile given 3 months investment horizon. GeneDx Holdings Corp holds Efficiency (Sharpe) Ratio of 0.23, which attests that the entity had a 0.23% return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.75% are justified by taking the suggested risk. Use GeneDx Holdings Corp Risk Adjusted Performance of 0.1592, market risk adjusted performance of 2.09, and Downside Deviation of 3.82 to evaluate company specific risk that cannot be diversified away. GeneDx Holdings holds a performance score of 18 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 0.7, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, GeneDx Holdings' returns are expected to increase less than the market. However, during the bear market, the loss of holding GeneDx Holdings is expected to be smaller as well. Use GeneDx Holdings Corp potential upside, as well as the relationship between the accumulation distribution and price action indicator , to analyze future returns on GeneDx Holdings Corp.
Auto-correlation | -0.25 |
Weak reverse predictability
GeneDx Holdings Corp has weak reverse predictability. Overlapping area represents the amount of predictability between GeneDx Holdings time series from 30th of October 2024 to 14th of November 2024 and 14th of November 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of GeneDx Holdings Corp price movement. The serial correlation of -0.25 indicates that over 25.0% of current GeneDx Holdings price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.25 | |
| Spearman Rank Test | -0.21 | |
| Residual Average | 0.0 | |
| Price Variance | 20.83 |
GeneDx Holdings Corp lagged returns against current returns
Autocorrelation, which is GeneDx Holdings stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting GeneDx Holdings' stock expected returns. We can calculate the autocorrelation of GeneDx Holdings returns to help us make a trade decision. For example, suppose you find that GeneDx Holdings has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
GeneDx Holdings regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If GeneDx Holdings stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if GeneDx Holdings stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in GeneDx Holdings stock over time.
Current vs Lagged Prices |
| Timeline |
GeneDx Holdings Lagged Returns
When evaluating GeneDx Holdings' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of GeneDx Holdings stock have on its future price. GeneDx Holdings autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, GeneDx Holdings autocorrelation shows the relationship between GeneDx Holdings stock current value and its past values and can show if there is a momentum factor associated with investing in GeneDx Holdings Corp.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.